VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CIA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CIACitizens, Inc.
$6.18$312M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCIAFinancials

Citizens, Inc. (CIA) Financials

30Y historyFree accessUpdated daily

Revenue growth remains muted at 4.33% year-over-year, while underwriting profitability remains under pressure with a combined ratio that fluctuated to 103.2% in 2025Q1.

CIA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue258.19M255.62M245M240.68M232.52M250.53M238.85M250.59M244.01M252.63M245.41M236.27M230.22M213.64M202.76M194.16M190.32M188.98M146.67M169.64M158.06M142.11M99.86M92.06M82.9M67.65M66.68M71.88M72.68M65.03M63.9M
Revenue Growth %6.28%4.33%1.8%3.51%-7.19%4.89%-4.69%2.7%-3.41%2.94%3.87%2.62%7.77%5.36%4.43%2.01%0.71%28.84%-13.54%7.33%11.22%42.31%8.47%11.05%22.55%1.45%-7.23%-1.11%11.78%1.76%20.27%
Medical Costs & Claims167.1M165.03M123.28M0117.73M122.4M191.92M190.32M188.01M202.96M197.67M191.86M183.3M168.24M159.5M145.72M135.16M94.32M84.91M73.31M138.68M138.4M56.78M88.53M78.43M58.85M59.72M72.2M40.16M37M30.1M
Medical Cost Ratio %64.72%64.56%50.32%0%50.63%48.86%80.35%75.95%77.05%80.34%80.55%81.2%79.62%78.75%78.67%75.05%71.02%49.91%57.89%43.22%87.74%97.39%56.87%96.17%94.61%87%89.57%100.44%55.25%56.9%47.1%
Gross Profit91.09M90.59M121.72M240.68M114.79M128.13M46.93M60.27M56M49.67M47.73M44.41M46.92M45.4M43.26M48.44M55.16M94.66M61.76M96.33M19.38M3.71M43.07M3.53M4.47M8.79M6.96M-319.4K32.53M28.03M33.8M
Gross Margin %35.28%35.44%49.68%100%49.37%51.14%19.65%24.05%22.95%19.66%19.45%18.8%20.38%21.25%21.33%24.95%28.98%50.09%42.11%56.78%12.26%2.61%43.13%3.83%5.39%13%10.43%-0.44%44.75%43.1%52.9%
Gross Profit Growth %--25.57%-49.43%109.67%-10.41%173.02%-22.14%7.64%12.74%4.06%7.49%-5.36%3.36%4.95%-10.7%-12.18%-41.73%53.26%-35.88%397.01%422.12%-91.38%1120.17%-21.03%-49.16%26.38%2278.28%-100.98%16.06%-17.08%5126.28%
Operating Expenses69.46M73.12M106.74M47.13M87.41M97.62M59.25M54.53M53.99M52.66M42.25M46.35M48.88M38.47M37.22M37.11M36.77M74.05M74.36M72.83M6.04M-8.08M03.28M-965.92K3.76M4.43M-1.29M38.21M24M0
OpEx / Revenue %26.9%28.61%43.57%19.58%37.59%38.97%24.81%21.76%22.13%20.84%17.22%19.62%21.23%18.01%18.36%19.11%19.32%39.18%50.7%42.93%3.82%-5.69%0%3.57%-1.17%5.56%6.65%-1.8%52.56%36.9%0%
Depreciation & Amortization653K741K619K1.12M536K1.14M1.42M1.68M1.45M1.06M2.87M3.1M3.3M3.67M3.7M4.05M4.11M4.6M4.01M4.28M5.95M7.93M5.46M7.8M3.32M738.45K608.53K510.75K12.09M2.81M1.4M
Combined Ratio %91.62%93.17%93.89%19.58%88.23%87.82%105.16%97.71%99.18%101.18%97.77%100.82%100.85%96.76%97.02%94.16%90.34%89.1%108.59%86.15%91.56%91.7%56.87%99.73%93.44%92.57%96.22%98.65%107.81%93.8%47.1%
Operating Income21.63M17.47M14.98M193.55M27.38M30.5M-12.32M5.75M2M-2.99M5.48M-1.94M-1.95M6.93M6.04M11.33M18.39M20.61M-12.6M23.5M13.34M11.8M43.07M245.56K5.44M5.03M2.52M972.45K-5.68M4.03M33.8M
Operating Margin %8.38%6.83%6.11%80.42%11.77%12.18%-5.16%2.29%0.82%-1.18%2.23%-0.82%-0.85%3.24%2.98%5.84%9.66%10.9%-8.59%13.85%8.44%8.3%43.13%0.27%6.56%7.43%3.78%1.35%-7.81%6.2%52.9%
Operating Income Growth %-16.62%-92.26%606.98%-10.25%347.67%-314.4%186.96%167.05%-154.46%382.19%0.36%-128.13%14.83%-46.73%-38.39%-10.76%263.6%-153.6%76.12%13.11%-72.61%17441.2%-95.48%8.1%99.25%159.52%117.13%-240.88%-88.08%800.96%
EBITDA22.28M18.21M15.6M194.67M27.91M31.64M-10.89M7.42M3.45M-1.92M8.35M1.15M1.35M10.6M9.74M15.38M22.5M25.21M-8.58M27.78M19.29M19.73M48.54M8.04M8.76M5.77M3.13M1.48M6.42M6.84M35.2M
EBITDA Margin %8.63%7.12%6.37%80.88%12%12.63%-4.56%2.96%1.42%-0.76%3.4%0.49%0.59%4.96%4.8%7.92%11.82%13.34%-5.85%16.37%12.2%13.88%48.6%8.74%10.57%8.53%4.7%2.06%8.83%10.52%55.09%
Interest Expense000000000000000000000000000100K27.01K77.87K0
Non-Operating Income000167.38M00000000830K00000000790-3.04M000-100K-27.01K-77.87K0
Pretax Income21.63M17.47M14.98M26.17M27.38M30.5M-12.32M5.75M2M-2.99M5.48M-1.94M-1.95M6.93M6.04M11.33M18.39M20.61M-12.6M23.5M13.34M11.8M8.09M3.29M5.54M5.03M2.52M972.45K-5.68M4.03M3.6M
Pretax Margin %8.38%6.83%6.11%10.88%11.77%12.18%-5.16%2.29%0.82%-1.18%2.23%-0.82%-0.85%3.24%2.98%5.84%9.66%10.9%-8.59%13.85%8.44%8.3%8.1%3.57%6.68%7.43%3.78%1.35%-7.81%6.2%5.63%
Income Tax3.15M2.88M68K1.74M1.37M-42.2M-1.33M7.12M13.06M35.14M3.51M1.2M4.02M2.14M1.51M2.85M3.69M3.27M3.11M6.94M4.67M4.49M356K162.06K1.28M1.07M471K-298.62K1.04M604.22K1.4M
Effective Tax Rate %14.56%16.48%0.45%6.64%5%-138.34%10.79%123.85%652.55%-1176.86%64.09%-61.76%-206.15%30.85%24.97%25.14%20.04%15.85%-24.71%29.54%34.96%38.1%4.4%4.93%23.2%21.19%18.66%-30.71%-18.38%14.99%38.89%
Net Income18.48M14.59M14.91M24.44M26.01M72.71M-10.99M-1.37M-11.06M-38.13M1.97M-3.14M-5.97M4.79M4.53M8.48M14.7M17.34M-15.71M16.56M8.68M7.3M7.73M3.13M4.25M3.96M2.05M1.27M-6.72M3.43M2.2M
Net Margin %7.16%5.71%6.09%10.15%11.18%29.02%-4.6%-0.55%-4.53%-15.09%0.8%-1.33%-2.59%2.24%2.23%4.37%7.73%9.18%-10.71%9.76%5.49%5.14%7.74%3.4%5.13%5.86%3.08%1.77%-9.25%5.27%3.44%
Net Income Growth %111.3%-2.15%-38.98%-6.04%-64.23%761.69%-702.04%87.62%70.99%-2036.36%162.65%47.35%-224.56%5.83%-46.6%-42.32%-15.2%210.4%-194.87%90.81%18.83%-5.56%147.34%-26.52%7.34%93.06%61.5%118.91%-296.19%55.71%-20.01%
EPS (Diluted)0.360.290.290.48-0.15-0.99-0.22-0.03-0.22-0.760.04-0.07-0.130.100.090.170.300.31-0.360.350.080.130.190.080.120.110.060.04-0.190.100.08
EPS Growth %114.62%0%-39.58%420%84.85%-350%-697.1%87.45%71.05%-2000%155.94%45%-230%11.11%-47.06%-43.33%-3.23%186.11%-202.86%337.5%-38.46%-31.58%143.28%-34.92%9.09%93.66%60%118.68%-290.95%30.75%-23.29%
EPS (Basic)-0.290.270.49-0.15-1.01-0.22-0.03-0.22-0.770.04-0.07-0.130.100.090.170.300.31-0.360.350.080.130.190.080.120.110.060.04-0.190.100.08
Diluted Shares Outstanding50.98M50.98M50.67M50.68M50.87M50.49M49.4M49.72M50.14M50.08M50.08M50.08M50.08M50.08M50.01M49.81M49.69M48.56M43.48M41.52M43.2M41.1M41M39.47M35.45M34.68M36.15M35.81M34.49M33.66M28.93M

Key Metrics

Growth RegimeStable
ProfitabilityStrained
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

International lapse rate volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Niche Premium Growth Remains Muted

According to reported financial data, Citizens, Inc. achieved a 4.33% year-over-year revenue growth rate, suggesting that the company is successfully maintaining its specialized international USD-denominated life insurance niche despite broader global economic volatility, though it currently lacks the catalysts required for more aggressive expansion.

The modest revenue growth reflects the company's reliance on a high-touch, relationship-based distribution model that is inherently difficult to scale rapidly. Investors should monitor whether the current growth trajectory can be sustained without significant investment in digital distribution or a broader expansion of the independent agency network.

Underwriting Profitability Faces Persistent Pressure

As indicated by the quarterly income statements, the combined ratio has fluctuated significantly, reaching a peak of 103.2% in 2025Q1, which highlights the company's vulnerability to underwriting volatility and the thin margins inherent in its current operational structure.

The inconsistency in the combined ratio suggests that the company struggles to maintain underwriting discipline across its diverse life and home service segments. The operating margin of 6.83% leaves little room for error, implying that any sustained increase in claims or administrative costs could quickly erode the company's bottom-line profitability.

Operational Efficiency and Margin Vulnerability

Based on the provided financial figures, the company's net margin of 5.71% warrants further investigation, as it appears to reflect the high costs of maintaining a complex international compliance infrastructure and a legacy-heavy domestic distribution network in the U.S. South.

The reliance on manual processes within the Home Service segment may be creating a structural drag on profitability that is not easily mitigated by current revenue growth. Analysts should consider whether the company's specialized moat is sufficient to offset the long-term risk of margin compression from rising administrative and commission expenses.

CIA — Frequently Asked Questions

Quick answers to the most common questions about buying CIA stock.

What was Citizens, Inc.'s (CIA) revenue in 2025?

For fiscal year 2025, Citizens, Inc. (CIA) reported total revenue of $255.6M. This represents a 300.0% increase compared to $63.9M in 1996.

Is Citizens, Inc. (CIA) profitable?

Citizens, Inc. (CIA) is profitable, generating $14.6M in net income for the fiscal year ending 2025 with a net profit margin of 5.7%.

What is Citizens, Inc.'s operating profit margin?

Citizens, Inc. (CIA) reported an operating income of $17.5M, resulting in an operating profit margin of 6.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Citizens, Inc.'s gross profit and gross margin?

Citizens, Inc. (CIA) generated $90.6M in gross profit for the year, representing a gross profit margin of 35.4%. This demonstrates the company's core pricing power and production efficiency.